AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2019

Nov 19, 2019

32870_dirs_2019-11-19_8f0d30e3-02fe-43ed-8711-6d753608f136.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2019-11-18

Reporting Person: Zoon Kathryn C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-18	Common Stock	S	1000	$54.314	Disposed	17412	Direct

Footnotes

F1: Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.

F2: The price reported is the weighted average sale price. These shares were sold in multiple transactions ranging from $54.24 to $54.34.